Merck & Company (MRK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $2.49
- Estimate
- $2.08
- Surprise
- +19.6%
- Score at report (before → after)
- 5.0 → 5.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Merck & Company (MRK) beat the $2.08 estimate with adjusted EPS of $2.49 — a large 19.6% upside surprise. TrendMatrix's engine moved from Hold (5.0/10) to Sell at 5.1/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MRK Sell at 4.8/10.
4 of the last 4 quarters beat the estimate; this quarter's +19.6% surprise compares with a +20.9% four-quarter average. Next scheduled report: 2027-02-02.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Thin upside margin: 9.5%
- Leverage penalty (D/E 1.2): -0.5
- Weak overall score: 4.8/10
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $132.81
- Price target
- $145.37
- Stop
- $127.42
- Upside to target
- +9.5%
- Reward-to-risk
- 1.4:1
The stock trades at 139.2× trailing but 15.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 25 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-19 — shown for context, not personalized investment advice.
MRK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $339.66B
- P/E (fwd)
- 15.4
- P/E (ttm)
- 139.2
- 52-week range
- $93.90–$156.92
- Off 52-week high
- 15.4%
- RSI (14)
- 25
- Volume vs avg
- 1.46×
- Score today
- 4.8/10